Sharechat Logo

NZ dollar climbs above 86 cents as economic prospects, high yields drive demand

Friday 12th April 2013

Text too small?

The New Zealand dollar continued its rally, topping 86 US cents and charting a new record on a trade-weighted basis as the nation's economic fundamentals and demand for high yields in a low-rate world drove demand.

The kiwi rose to 86.32 US cents from 85.92 cents at 5pm in Wellington yesterday. The trade-weighted index rose to 79.36 from 79.11.

Stocks on Wall Street have set new record highs, keeping intact global risk-on sentiment and demand for the currency of a central bank whose key interest rate is as much as 250 basis points higher than the Federal Reserve's. New Zealand's outlook for economic growth stands out in the face of a contracting euro-zone and stumbles in the US.

"Offshore speculative and leveraged players continue to show appetite for the higher yield and positive economic story of the NZD," Mike Jones, strategist at Bank of New Zealand, said in his morning note.

Underlining the appeal of the nation's yields, investors bid $2.8 billion for $2 billion of 2020 government bonds that went on sale this week, he said.

The kiwi rose to 81.84 Australian cents from 81.66 cents and climbed to 86.18 yen from 85.58 yen. It edged up to 65.87 euro cents from 65.79 cents and rose to 56.10 British pence from 56.05 pence.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors